[144] Idexx Laboratories Inc SEC Filing
Idexx Laboratories (IDXX) Form 144 notice: An insider intends to sell 2,187 shares of common stock, representing an aggregate market value of $1,415,700.21, on 08/22/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired the same day via stock option exercise and paid in cash. There were 80,004,694 shares outstanding reported for the issuer. The filer reports no sales in the prior three months. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Avviso Form 144 di Idexx Laboratories (IDXX): Un insider intende vendere 2.187 azioni ordinarie, per un valore complessivo di mercato di $1.415.700,21, il 22/08/2025 tramite Morgan Stanley Smith Barney LLC su NASDAQ. Le azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni su azioni e saldate in contanti. L'emittente ha riportato 80.004.694 azioni in circolazione. Il dichiarante segnala nessuna vendita nei tre mesi precedenti e certifica di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate riguardanti l'emittente.
Aviso Form 144 de Idexx Laboratories (IDXX): Un insider tiene la intenci贸n de vender 2.187 acciones ordinarias, con un valor de mercado agregado de $1.415.700,21, el 22/08/2025 a trav茅s de Morgan Stanley Smith Barney LLC en NASDAQ. Las acciones fueron adquiridas el mismo d铆a mediante el ejercicio de opciones sobre acciones y pagadas en efectivo. La emisora declar贸 que hab铆a 80.004.694 acciones en circulaci贸n. El declarante informa no haber realizado ventas en los tres meses anteriores y certifica que no conoce informaci贸n material adversa no divulgada sobre la emisora.
Idexx Laboratories(IDXX) Form 144 瓿奠嫓: 雮措秬鞛愱皜 2,187欤� 氤错喌欤茧ゼ 毵る弰頃� 鞚橃偓毳� 氚濏様鞙茧┌, 齑� 鞁滉皜鞎§潃 $1,415,700.21搿� 2025-08-22鞐� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NASDAQ鞐愳劀 毵る弰霅� 鞓堨爼鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 霃欖澕頃� 雮� 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 旆摑霅橃棃瓿� 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 氚滍枆靷姅 80,004,694欤检潣 鞙犿喌欤检嫕鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈臧勳潣 毵る弰 鞐嗢潓鞚� 氤搓碃頃橂┌, 氚滍枆鞚胳棎 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃╇媹雼�.
Avis Form 144 d'Idexx Laboratories (IDXX) : Un initi茅 a l'intention de vendre 2 187 actions ordinaires, repr茅sentant une valeur marchande totale de 1 415 700,21 $, le 22/08/2025 via Morgan Stanley Smith Barney LLC sur le NASDAQ. Les actions ont 茅t茅 acquises le m锚me jour par exercice d'options sur actions et r茅gl茅es en 别蝉辫猫肠别蝉. L'茅metteur a d茅clar茅 80 004 694 actions en circulation. Le d茅clarant indique aucune vente au cours des trois mois pr茅c茅dents et certifie ne pas 锚tre au courant d'informations d茅favorables mat茅rielles non divulgu茅es concernant l'茅metteur.
Form-144-Mitteilung von Idexx Laboratories (IDXX): Ein Insider beabsichtigt, 2.187 Stammaktien zu verkaufen, mit einem aggregierten Marktwert von $1.415.700,21, am 22.08.2025 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ. Die Aktien wurden am selben Tag durch Aus眉bung von Aktienoptionen erworben und in Bargeld bezahlt. F眉r den Emittenten wurden 80.004.694 ausstehende Aktien gemeldet. Der Einreicher berichtet 眉ber keine Verk盲ufe in den vorangegangenen drei Monaten und best盲tigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen zum Emittenten bekannt sind.
- Complete disclosure of broker, number of shares, aggregate value, acquisition method, and payment type
- No sales in prior three months, suggesting this is not part of ongoing heavy insider selling
- Securities were acquired by option exercise and paid in cash, indicating standard compensation monetization
- None.
Insights
TL;DR: Insider plans to sell a small block of shares acquired by option exercise; transaction appears routine and non-recurring.
The notice shows an insider executed options and intends to sell 2,187 shares valued at $1,415,700.21 through a broker on the Nasdaq exchange. The shares were acquired and are to be sold on the same date and were paid for in cash, which is consistent with option exercise followed by an immediate disposition. No other sales were reported in the prior three months, suggesting this is not part of a recurring disposal pattern. As a percentage of the outstanding share count (80,004,694), the block is immaterial from a dilution or control standpoint. The filing contains the required representation that no undisclosed material adverse information exists.
TL;DR: Disclosure aligns with Rule 144 procedural requirements; transaction raises no immediate governance concerns.
The Form 144 provides the broker name, size, market value, acquisition method, and payment type, meeting standard disclosure elements. The simultaneous acquisition by exercise and planned sale may reflect routine option monetization. The absence of aggregated sales in the prior three months reduces concern about concentrated insider selling. The filing includes the signature representation about material information, which is standard and important for compliance.
Avviso Form 144 di Idexx Laboratories (IDXX): Un insider intende vendere 2.187 azioni ordinarie, per un valore complessivo di mercato di $1.415.700,21, il 22/08/2025 tramite Morgan Stanley Smith Barney LLC su NASDAQ. Le azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni su azioni e saldate in contanti. L'emittente ha riportato 80.004.694 azioni in circolazione. Il dichiarante segnala nessuna vendita nei tre mesi precedenti e certifica di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate riguardanti l'emittente.
Aviso Form 144 de Idexx Laboratories (IDXX): Un insider tiene la intenci贸n de vender 2.187 acciones ordinarias, con un valor de mercado agregado de $1.415.700,21, el 22/08/2025 a trav茅s de Morgan Stanley Smith Barney LLC en NASDAQ. Las acciones fueron adquiridas el mismo d铆a mediante el ejercicio de opciones sobre acciones y pagadas en efectivo. La emisora declar贸 que hab铆a 80.004.694 acciones en circulaci贸n. El declarante informa no haber realizado ventas en los tres meses anteriores y certifica que no conoce informaci贸n material adversa no divulgada sobre la emisora.
Idexx Laboratories(IDXX) Form 144 瓿奠嫓: 雮措秬鞛愱皜 2,187欤� 氤错喌欤茧ゼ 毵る弰頃� 鞚橃偓毳� 氚濏様鞙茧┌, 齑� 鞁滉皜鞎§潃 $1,415,700.21搿� 2025-08-22鞐� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NASDAQ鞐愳劀 毵る弰霅� 鞓堨爼鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 霃欖澕頃� 雮� 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 旆摑霅橃棃瓿� 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 氚滍枆靷姅 80,004,694欤检潣 鞙犿喌欤检嫕鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈臧勳潣 毵る弰 鞐嗢潓鞚� 氤搓碃頃橂┌, 氚滍枆鞚胳棎 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃╇媹雼�.
Avis Form 144 d'Idexx Laboratories (IDXX) : Un initi茅 a l'intention de vendre 2 187 actions ordinaires, repr茅sentant une valeur marchande totale de 1 415 700,21 $, le 22/08/2025 via Morgan Stanley Smith Barney LLC sur le NASDAQ. Les actions ont 茅t茅 acquises le m锚me jour par exercice d'options sur actions et r茅gl茅es en 别蝉辫猫肠别蝉. L'茅metteur a d茅clar茅 80 004 694 actions en circulation. Le d茅clarant indique aucune vente au cours des trois mois pr茅c茅dents et certifie ne pas 锚tre au courant d'informations d茅favorables mat茅rielles non divulgu茅es concernant l'茅metteur.
Form-144-Mitteilung von Idexx Laboratories (IDXX): Ein Insider beabsichtigt, 2.187 Stammaktien zu verkaufen, mit einem aggregierten Marktwert von $1.415.700,21, am 22.08.2025 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ. Die Aktien wurden am selben Tag durch Aus眉bung von Aktienoptionen erworben und in Bargeld bezahlt. F眉r den Emittenten wurden 80.004.694 ausstehende Aktien gemeldet. Der Einreicher berichtet 眉ber keine Verk盲ufe in den vorangegangenen drei Monaten und best盲tigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen zum Emittenten bekannt sind.
FAQ
What does the Form 144 for IDXX disclose?
How were the shares acquired according to the filing?
Does the Form 144 show other recent insider sales?
How large is the sale relative to outstanding shares?
Which broker will handle the sale?
